In the past trading session, U.S. stocks were in red due to the ripple effect of the deepest Chinese equities sell-off yesterday since 2007. Doubts over the sustainability of Chinese government funds’ ability to soothe the market led to a pullback in market support. The panic took an acute turn after industrial profits in China slipped 0.3% in June stoking growth concerns relating to the Chinese economy.
As the Shanghai index plunged 8.5% and the Shenzhen lost 7%, it left an adverse impact all over the globe. Among the top ETFs, investors saw SPY lose 0.6%, DIA shed over 0.7% and QQQ move lower by over 0.8% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs ones to watch in the days ahead to see if this trend of extra-interest continues:
(IYH - Free Report) : Volume 3.95 times average
This U.S. health care ETF was in focus yesterday as roughly 880,500 shares moved hands compared to an average of roughly 223,120 shares. We also saw some stock price movement as shares of IYH dropped 0.1% yesterday, though the slump appears mainly the cause of a broader market retreat.
The move yesterday was largely the result of Teva Pharmaceutical’s (TEVA) confirmation that it will acquire Allergan Plc’s (AGN) generic drug business for roughly $40.5 billion as this can have a big impact on Allergan Plc, a key constituent of this ETF’s portfolio. For the month, IYH is up 0.81% and has a Zacks ETF Rank #2 (Buy).
(VIS - Free Report) : Volume 3.25 times average
This U.S. industrial ETF was under the microscope yesterday as nearly 274,250 shares moved hands. This compares to an average trading day of 84,270 shares. VIS lost 0.6% on the session.
The movement can be attributed to tepid earnings, weaker oil prices and the Chinese market rout. VIS was down over 2.8% in the past month; though the fund currently has a Zacks ETF Rank #3 (Hold).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>